[go: up one dir, main page]

NO942756D0 - Behandling av glaucoma - Google Patents

Behandling av glaucoma

Info

Publication number
NO942756D0
NO942756D0 NO942756A NO942756A NO942756D0 NO 942756 D0 NO942756 D0 NO 942756D0 NO 942756 A NO942756 A NO 942756A NO 942756 A NO942756 A NO 942756A NO 942756 D0 NO942756 D0 NO 942756D0
Authority
NO
Norway
Prior art keywords
glaucoma
treatment
Prior art date
Application number
NO942756A
Other languages
English (en)
Other versions
NO942756L (no
Inventor
William Cash
Georg Mathis
Marc De Gasparo
Original Assignee
Ciba Vision Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Vision Ag filed Critical Ciba Vision Ag
Publication of NO942756L publication Critical patent/NO942756L/no
Publication of NO942756D0 publication Critical patent/NO942756D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO942756A 1992-02-17 1994-07-22 Behandling av glaucoma NO942756D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH45992 1992-02-17
PCT/US1993/001431 WO1993015732A1 (en) 1992-02-17 1993-02-17 Treatment of glaucoma

Publications (2)

Publication Number Publication Date
NO942756L NO942756L (no) 1994-07-22
NO942756D0 true NO942756D0 (no) 1994-07-22

Family

ID=4187501

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942756A NO942756D0 (no) 1992-02-17 1994-07-22 Behandling av glaucoma

Country Status (8)

Country Link
EP (1) EP0626846A1 (no)
JP (1) JPH07504099A (no)
AU (1) AU3722493A (no)
CA (1) CA2128324A1 (no)
IL (1) IL104755A0 (no)
NO (1) NO942756D0 (no)
WO (1) WO1993015732A1 (no)
ZA (1) ZA931063B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0743852T3 (da) * 1994-02-08 2005-10-17 Novartis Ag Behandling af glaukom med normalt tryk med valsartan
PL316259A1 (en) * 1994-03-17 1997-01-06 Ciba Geigy Ag Treatment of diabetic nephropathy with valsartan
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
US6673812B1 (en) 1998-08-17 2004-01-06 Senju Pharmaceutical Co., Ltd. Preventives/remedies for glaucoma
EP1112749A4 (en) * 1998-08-20 2004-06-16 Senju Pharma Co PROPHYLAXIS OR REMEDIES FOR CIRCULATORY EYE DISTURBANCE
AU774799B2 (en) * 1999-04-28 2004-07-08 Takeda Pharmaceutical Company Limited Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy
TW200304812A (en) * 2002-03-08 2003-10-16 Sankyo Co An eye drop containing a tetrazole derivative
FR2878522B1 (fr) * 2004-12-01 2008-04-18 Merck Sante Soc Par Actions Si Nouveaux inhibiteurs specifiques de la caspas-10

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036048A (en) * 1986-03-07 1991-07-30 Schering Corporation Angiotensin II receptor blockers as antiglaucoma agents
PH30484A (en) * 1990-02-19 1997-05-28 Ciba Geigy Acy compounds pharmaceutical composition containing said compound and method of use thereof
TW201738B (no) * 1990-03-20 1993-03-11 Sanofi Co
FR2672891B1 (fr) * 1991-02-20 1994-02-18 Synthelabo Derives de 3-pyrazolones, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
JPH07504099A (ja) 1995-05-11
ZA931063B (en) 1993-09-23
IL104755A0 (en) 1993-06-10
CA2128324A1 (en) 1993-08-19
NO942756L (no) 1994-07-22
EP0626846A1 (en) 1994-12-07
AU3722493A (en) 1993-09-03
WO1993015732A1 (en) 1993-08-19

Similar Documents

Publication Publication Date Title
NO934547D0 (no) Oral behandling av Helicobacter-in-feksjon
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
NO934304L (no) Fremgangsmaate for behandling av fluoralumosilikatglass
FI935223A0 (fi) RAKE-mottagare med selektiv kombinering av straolar
FI935135A0 (fi) Foerfarande foer rening av TiO2-malm
FI933902A7 (fi) Substituoidut sykloheksaanijohdannaiset sairauksien hoitamiseksi
GB2269164B (en) Treatment of polyvinylchloride
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
NO942756D0 (no) Behandling av glaucoma
NO932860D0 (no) Fremgangsmaate for fremstilling av kalsium-l-askorbat-2-fosfat
NO940190D0 (no) Anvendelse av x-ketoglutarat
NO920983L (no) Fremgangsmaate for behandling av nevrodegenerative tilstander
NO921720L (no) Behandling av brystkjertelbetennelse
NO923799L (no) Behandling av korn
NO171565C (no) Fremgangsmaate for behandling av manganslam
KR930026760U (ko) Tvcr의 개선된 구성
NO931803D0 (no) Behandling av vevsulkerasjon
NO950335D0 (no) Behandling av titanholdige materialer
NO941063D0 (no) Behandling av faststoffmateriale
DK103092D0 (da) Fremgangsmaade
DK86992D0 (da) Fremgangsmaade
DK80592D0 (da) Fremgangsmaade
FI39U1 (fi) Anordning foer flottning av naet under is
FI952479A0 (fi) Stenoosin ehkäisy
NO921003L (no) Forbindelser for behandling av leukotrien-relaterte sykdommer